Leader
|
|
|
00000nz a2200037oc 45 0 |
001
|
|
|
DNB|1173906827
(VIAF cluster)
|
003
|
|
|
DNB |
005
|
|
|
20240226220101.0 |
008
|
|
|
181220n||aznnnaabn | aaa |c |
035
|
|
|
‡a
(DNB)1173906827
|
024
|
7 |
|
‡a
1173906827
‡0
http://d-nb.info/gnd/1173906827
‡2
gnd
|
024
|
7 |
|
‡a
0000-0001-9215-803X
‡9
v:Herkunft: base
‡2
orcid
|
035
|
|
|
‡a
(DE-101)1173906827
|
035
|
|
|
‡a
(DE-588)1173906827
|
040
|
|
|
‡a
DE-206
‡c
DE-206
‡9
r:DE-206
‡b
ger
‡d
9999
‡e
rda
|
042
|
|
|
‡a
gnd3
|
043
|
|
|
‡c
XA-GB
|
075
|
|
|
‡b
p
‡2
gndgen
|
075
|
|
|
‡b
piz
‡2
gndspec
|
079
|
|
|
‡a
g
‡q
f
|
100
|
1 |
|
‡a
Smyth, Michael
|
375
|
|
|
‡a
1
‡2
iso5218
|
400
|
1 |
|
‡a
Smyth, Michael D.
|
672
|
|
0 |
‡a
Wilson, Michele R.: Cost-effectiveness of vedolizumab compared with infliximab, adalimumab, and golimumab in patients with ulcerative colitis in the United Kingdom
‡f
2018
|
678
|
|
|
‡b
Takeda Development Centre Europe Ltd., London, UK
|
909
|
|
|
‡a
(gnd) 1173906827
‡9
1
|
909
|
|
|
‡a
(orcid) 000000019215803x
‡9
1
|
946
|
|
|
‡a
b
‡9
1
|
947
|
|
|
‡a
GB
‡9
1
|
996
|
|
|
‡2
ISNI|0000000084421822
|
996
|
|
|
‡2
J9U|987007365216905171
|
996
|
|
|
‡2
ISNI|0000000101019246
|
996
|
|
|
‡2
NUKAT|n 2013236927
|
996
|
|
|
‡2
WKP|Q6838791
|
996
|
|
|
‡2
N6I|vtls000111527
|
996
|
|
|
‡2
ISNI|0000000439713454
|
996
|
|
|
‡2
BIBSYS|90232399
|
996
|
|
|
‡2
SUDOC|237083825
|
996
|
|
|
‡2
PLWABN|9810563302905606
|
996
|
|
|
‡2
N6I|vtls002303675
|
996
|
|
|
‡2
WKP|Q86493330
|
996
|
|
|
‡2
NUKAT|n 2013183817
|
996
|
|
|
‡2
J9U|987007446099105171
|
996
|
|
|
‡2
NTA|146024826
|
996
|
|
|
‡2
N6I|vtls000025491
|
996
|
|
|
‡2
WKP|Q92203308
|
996
|
|
|
‡2
ISNI|0000000382793122
|
996
|
|
|
‡2
NSK|000650454
|
996
|
|
|
‡2
LC|nr 88004542
|
996
|
|
|
‡2
ISNI|0000000083172190
|
996
|
|
|
‡2
LC|no2014008361
|
996
|
|
|
‡2
LC|n 2022244162
|
996
|
|
|
‡2
NTA|318988240
|
996
|
|
|
‡2
SUDOC|17066435X
|
996
|
|
|
‡2
BNF|17932649
|
996
|
|
|
‡2
WKP|Q6834488
|
996
|
|
|
‡2
ISNI|0000000120076537
|
996
|
|
|
‡2
LC|no2013083772
|
996
|
|
|
‡2
ISNI|0000000026133793
|
996
|
|
|
‡2
NUKAT|n 2012213682
|
996
|
|
|
‡2
SUDOC|154891894
|
996
|
|
|
‡2
WKP|Q75239608
|
996
|
|
|
‡2
ISNI|0000000045900441
|
996
|
|
|
‡2
LC|nb 99154954
|
996
|
|
|
‡2
NLA|000035508776
|
996
|
|
|
‡2
LC|no2003101537
|
996
|
|
|
‡2
WKP|Q16007493
|
996
|
|
|
‡2
ISNI|0000000039271634
|
996
|
|
|
‡2
NII|DA08882650
|
996
|
|
|
‡2
NUKAT|n 2020162840
|
996
|
|
|
‡2
LC|n 87103169
|
996
|
|
|
‡2
LC|n 2011033271
|
996
|
|
|
‡2
SUDOC|12497211X
|
996
|
|
|
‡2
WKP|Q83993489
|
996
|
|
|
‡2
LC|n 91010577
|
996
|
|
|
‡2
RERO|A008638217
|
996
|
|
|
‡2
BIBSYS|2018827
|
996
|
|
|
‡2
NUKAT|n 2012074655
|
996
|
|
|
‡2
WKP|Q6838441
|
996
|
|
|
‡2
NUKAT|n 01032788
|
996
|
|
|
‡2
LC|nb2010022105
|
996
|
|
|
‡2
NSK|000368475
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
998
|
|
|
‡a
Smyth, Michael
‡2
LC|nb 99154954
‡3
exact name
|
998
|
|
|
‡a
Smyth, Michael
‡2
NSK|000650454
‡3
exact name
|
998
|
|
|
‡a
Smyth, Michael.
‡2
NUKAT|n 2012213682
‡3
exact name
|
998
|
|
|
‡a
Smyth, Michael
‡2
SUDOC|237083825
‡3
exact name
|
998
|
|
|
‡a
Smyth, Michael
‡2
RERO|A008638217
‡3
exact name
|
998
|
|
|
‡a
Smyth, Michael
‡2
J9U|987007446099105171
‡3
exact name
|